Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Atip Likidlilid"'
Autor:
Damrus Tresukosol, Bhoom Suktitipat, Saowalak Hunnangkul, Ruttakarn Kamkaew, Saiphon Poldee, Boonrat Tassaneetrithep, Atip Likidlilid
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110188 (2014)
Clopidogrel is an antiplatelet prodrug that is recommended to reduce the risk of recurrent thrombosis in coronary artery disease (CAD) patients. Paraoxonase 1 (PON1) is suggested to be a rate-limiting enzyme in the conversion of 2-oxo-clopidogrel to
Externí odkaz:
https://doaj.org/article/6423afbc34c34773886c2b4ca5dfedd2
Autor:
Thavatchai Peerapatdit, Atip Likidlilid, Natchai Patchanans, Nednapis Tirawanchai, Charn Sriratanasathavorn
Publikováno v:
Siriraj Medical Journal, Vol 56, Iss 2 (2004)
Objectives : Hyperglycemia is claimed to cause oxidative stress in diabetic (DM) patients. The influence of free radical production by hyperglycemia may exacerbate the cardiovascular complications in diabetes. However, the effects of glycemic control
Externí odkaz:
https://doaj.org/article/3d37263691994b59b791cfc2aeaf69ec
Publikováno v:
Acta Cardiologica. 65:681-691
Objective - Two common polymorphisms of the paraoxonase (PON 1) gene, L55M and Q192R, were proven to mitigate atherosclerosis pathogenesis by protecting lipoproteins against peroxidation. This study was to evaluate the associations between both PON1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772e613bf61f460a10bd121f543fbde7
https://doi.org/10.1080/ac.65.6.2059866
https://doi.org/10.1080/ac.65.6.2059866
Autor:
Rajesh Chaudhary, Suphachai Ratanamaneechat, Atip Likidlilid, Damras Tresukosol, Thavatchai Peerapatdit, Sorachai Srisuma, Charn Sriratanasathavorn
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 11, Iss 1, p 36 (2012)
Cardiovascular Diabetology, Vol 11, Iss 1, p 36 (2012)
Background The most common apolipoprotein E (apoE) gene polymorphism has been found to influence plasma lipid concentration and its correlation with coronary artery disease (CAD) has been extensively investigated in the last decade. It is, however, u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fda456e94178652026aca07af033913
https://pubmed.ncbi.nlm.nih.gov/22520940
https://pubmed.ncbi.nlm.nih.gov/22520940
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 90(9)
Diabetic (DM) patients are claimed to be under oxidative stress because of hyperglycemia. The influence of free radical production by this hyperglycemic induction may involve cardiovascular complications in diabetes. The present study aimed to compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4eee1d8fb4f895adf50220f8eb9d6fea
https://pubmed.ncbi.nlm.nih.gov/17957916
https://pubmed.ncbi.nlm.nih.gov/17957916
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 89
In Type 1 diabetes mellitus (DM), hyperglycemia is considered a primary cause of diabetic vascular complications and is associated with oxidative stress. The role of antioxidants, particularly alpha tocopherol, in Type 1 DM and its contribution in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::52748cd7e6567473dea646a4243dd54c
https://pubmed.ncbi.nlm.nih.gov/17718255
https://pubmed.ncbi.nlm.nih.gov/17718255
Autor:
Thavatchai, Peerapatdit, Natchai, Patchanans, Atip, Likidlilid, Saiphon, Poldee, Charn, Sriratanasathavorn
Publikováno v:
Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 89
Observation shows diabetic patients to be more prone to oxidative stress because of hyperglycemia. The elevation of free radical production by this hyperglycemic production may exacerbate cardiovascular complication in diabetes. This study aims to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::538e69689764b70b42f8b7796bcb4cb4
https://pubmed.ncbi.nlm.nih.gov/17718256
https://pubmed.ncbi.nlm.nih.gov/17718256
Autor:
Charn Sriratanasathavorn, R. Chantawee, S. Ratnamaneechat, D. Tresukosol, Thavatchai Peerapatdit, Atip Likidlilid
Publikováno v:
Atherosclerosis Supplements. 9:238-239
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37dd42b8339d835f27eca8387133187b
https://doi.org/10.1016/s1567-5688(08)70953-x
https://doi.org/10.1016/s1567-5688(08)70953-x
Publikováno v:
Atherosclerosis Supplements. 11:34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c57742a6ee0052fc1b6010fc10f05267
https://doi.org/10.1016/s1567-5688(10)70153-7
https://doi.org/10.1016/s1567-5688(10)70153-7
Publikováno v:
Atherosclerosis Supplements. 11:199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76b3455ccd3fa428ee5f6709826433bb
https://doi.org/10.1016/s1567-5688(10)70943-0
https://doi.org/10.1016/s1567-5688(10)70943-0